Khosro Keshavarz

737 total citations
65 papers, 440 citations indexed

About

Khosro Keshavarz is a scholar working on Economics and Econometrics, Finance and Epidemiology. According to data from OpenAlex, Khosro Keshavarz has authored 65 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 9 papers in Finance and 9 papers in Epidemiology. Recurrent topics in Khosro Keshavarz's work include Healthcare Systems and Reforms (9 papers), Economic and Financial Impacts of Cancer (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Khosro Keshavarz is often cited by papers focused on Healthcare Systems and Reforms (9 papers), Economic and Financial Impacts of Cancer (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Khosro Keshavarz collaborates with scholars based in Iran, United Kingdom and Australia. Khosro Keshavarz's co-authors include Shekoufeh Nikfar, Zahra Kavosi, Abbas Kebriaeezadeh, Farhad Hosseinzadeh Lotfı, Ramin Ravangard, Mohsen Bayati, Seyed Moayed Alavian, Ali Akbari Sari, Maryam Keshvari and Ahmad Gholami and has published in prestigious journals such as SHILAP Revista de lepidopterología, BioMed Research International and BMC Health Services Research.

In The Last Decade

Khosro Keshavarz

57 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khosro Keshavarz Iran 11 126 63 60 60 52 65 440
Xiaomo Xiong United States 11 104 0.8× 24 0.4× 47 0.8× 65 1.1× 72 1.4× 23 352
Randa Eldessouki Egypt 5 152 1.2× 37 0.6× 70 1.2× 60 1.0× 17 0.3× 14 478
Gaurav Jyani India 12 124 1.0× 65 1.0× 77 1.3× 112 1.9× 22 0.4× 26 399
Abhinav Bassi United Kingdom 9 90 0.7× 18 0.3× 119 2.0× 202 3.4× 28 0.5× 18 553
Atiqa Khalid Pakistan 7 41 0.3× 90 1.4× 35 0.6× 105 1.8× 128 2.5× 15 477
Susan Spillane United States 13 63 0.5× 121 1.9× 124 2.1× 159 2.6× 76 1.5× 23 708
Mohammed Alassiri Saudi Arabia 15 40 0.3× 171 2.7× 126 2.1× 81 1.4× 35 0.7× 36 649
Chunping Wang China 12 21 0.2× 15 0.2× 56 0.9× 114 1.9× 39 0.8× 52 458

Countries citing papers authored by Khosro Keshavarz

Since Specialization
Citations

This map shows the geographic impact of Khosro Keshavarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khosro Keshavarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khosro Keshavarz more than expected).

Fields of papers citing papers by Khosro Keshavarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khosro Keshavarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khosro Keshavarz. The network helps show where Khosro Keshavarz may publish in the future.

Co-authorship network of co-authors of Khosro Keshavarz

This figure shows the co-authorship network connecting the top 25 collaborators of Khosro Keshavarz. A scholar is included among the top collaborators of Khosro Keshavarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khosro Keshavarz. Khosro Keshavarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Salesi, Mahmood, et al.. (2023). Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis. Cost Effectiveness and Resource Allocation. 21(1). 10–10. 6 indexed citations
4.
Keshavarz, Khosro, et al.. (2022). Economic burden of major depressive disorder: a case study in Southern Iran. BMC Psychiatry. 22(1). 577–577. 12 indexed citations
5.
Morowvat, Mohammad Hossein, et al.. (2022). Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis. BMC Health Services Research. 22(1). 118–118. 8 indexed citations
6.
Vazin, Afsaneh, et al.. (2022). Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations. Value in Health Regional Issues. 33. 99–108. 3 indexed citations
7.
Gholami, Ahmad, et al.. (2021). Cost‐Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept. BioMed Research International. 2021(1). 4450162–4450162. 19 indexed citations
8.
Rezaee, Rita, et al.. (2021). Activity Based Costing (ABC) to Calculate the Cost of Training Students in School of Management and Medical Information Sciences. SHILAP Revista de lepidopterología.
9.
Keshavarz, Khosro, et al.. (2021). The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran. BMC Health Services Research. 21(1). 132–132. 75 indexed citations
10.
Khorasani, Elahe, et al.. (2020). Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews. International Journal of Psychiatry in Clinical Practice. 24(4). 357–370. 17 indexed citations
11.
Dehghani, Mehdi, et al.. (2019). Cost-utility Analysis of the EOX Drug Regimen versus the DCF Drug Regimen for Patients with Advanced Gastric Cancer. SHILAP Revista de lepidopterología. 10(2). 118–124. 2 indexed citations
12.
Ravangard, Ramin, et al.. (2018). Cost - effectiveness and Cost - utility of CinnoVex versus ReciGen in Patients with Relapsing - Remitting Multiple Sclerosis in Iran. Shiraz E-Medical Journal. In Press(In Press). 3 indexed citations
13.
Keshavarz, Khosro, et al.. (2018). Estimating the Cost of Illness of Prostate Cancer in Iran. Clinical Therapeutics. 41(1). 50–58. 21 indexed citations
14.
Kavosi, Zahra, et al.. (2016). Cost-effectiveness of radiotherapy during surgery compared with external radiation therapy in the treatment of women with breast cancer. SHILAP Revista de lepidopterología. 4 indexed citations
15.
Keshavarz, Khosro, et al.. (2015). Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness. SHILAP Revista de lepidopterología. 1. 6–9. 1 indexed citations
16.
Keshavarz, Khosro, et al.. (2015). Survey of Appropriate Use of Magnetic Resonance Imaging Services Provided in Shahid Chamran Hospital of Shiraz. Journal of Health Research. 1(3). 33–40. 2 indexed citations
17.
18.
Keshavarz, Khosro, et al.. (2012). A Geographic Information System Analysis of Accessibility to Community Pharmacy in Shiraz, Iran. Iranian journal of pharmaceutical sciences. 8(4). 283–288. 1 indexed citations
19.
Arab, Mohammad, et al.. (2012). Technical efficiency analyses in hospitals of Tabriz University of Medical Sciences. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Keshavarz, Khosro, et al.. (2011). The Effects of Drug Subsidies Exclusion on Price Index of Sectors and Household`s Expenditures Using Structural Path Analysis. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaomo Xiong Breakdown of academic impact, for papers by Randa Eldessouki Breakdown of academic impact, for papers by Gaurav Jyani Breakdown of academic impact, for papers by Abhinav Bassi Breakdown of academic impact, for papers by Atiqa Khalid Breakdown of academic impact, for papers by Susan Spillane Breakdown of academic impact, for papers by Mohammed Alassiri Breakdown of academic impact, for papers by Chunping Wang
Rankless by CCL
2026